Medications

Antiviral drug protects hamsters against COVID-19

The SARS-CoV-2 anti-viral drug, PF-07321332, can protect Syrian hamsters against infection with some SARS-CoV-2 variants of concern and reduces the risk of transmission, suggests a study published in Nature Communications.

Diseases, Conditions, Syndromes

Helping the body overcome SARS-CoV-2

As messenger substances, interferons stimulate various responses of immune cells and play a key role in activating the immune system. They are proven active agents against various diseases, especially type I interferon alpha ...

Oncology & Cancer

New path to treat advanced triple-negative breast cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...

Diseases, Conditions, Syndromes

Hospital room surfaces pose low risk of spreading SARS-CoV-2

Hospital rooms where COVID patients were treated had little to no active virus contaminations on surfaces, according to a study at Duke University Hospital that adds to the body of research on how the pandemic respiratory ...

page 11 from 40